Stay updated on GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.

Latest updates to the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.6.3 has replaced v3.6.2 on the study page, indicating a minor update to the document version referenced in the record. This update pertains to the study's documentation and does not change the content or results presented on the page.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a minor update. This does not appear to modify the study information or user-facing content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRecruitment status is updated to indicate the study is not enrolling participants, influencing the ability to join. The page also adds new navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and a formatting update to the Intervention/Treatment header, along with a Revision: v3.6.0 label.SummaryDifference0.3%

- Check34 days agoChange DetectedRevision label updated to v3.5.5. This replaces the previous v3.5.4 and indicates a newer revision of the document.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a minor update to the page version. This change reflects a maintenance version bump rather than alterations to study details or content.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page’s footer release/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site software update without changing the study record content.SummaryDifference0.0%

Stay in the know with updates to GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.